Nov 13 (Reuters)-
Fuji Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Sep 30, 2015 Sep 30, 2014 Sep 30, 2016 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 31.68 29.22 34.47 16.99
(+8.4 pct) (+16.1 pct) (+8.8 pct) (+9.9 pct)
Operating 3.25 3.17 3.48 1.80
(+2.5 pct) (-2.7 pct) (+7.0 pct) (+24.9 pct)
Recurring 3.10 3.20 3.43 1.78
(-3.1 pct) (-5.3 pct) (+10.7 pct) (+20.5 pct)
Net 2.09 2.08
(+0.6 pct) (+0.5 pct)
Net 2.23 1.15
(+6.6 pct) (+32.0 pct)
EPS 137.55 yen 140.53 yen 146.61 yen 75.60 yen
Ann Div 44.00 yen 44.00 yen 45.00 yen
-Q2 Div 20.00 yen 20.00 yen 21.00 yen
-Q4 Div 24.00 yen 24.00 yen 24.00 yen
NOTE - Fuji Pharmaceutical Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T
((Tokyo Headline News Desk +813 6441 1812))